Product group

An immunomodulatory thalidomide analogue prescribed—usually with dexamethasone—for patients with relapsed or refractory multiple myeloma and explored in other hematologic cancers.

  • Product group: Immunomodulatory (IMiD) anticancer API
  • Common applications:  Relapsed/refractory multiple myeloma and other investigational hematologic indication
  • CAS: 19171-19-8
  • Synonyms: 4-Aminothalidomide, CC-4047